terazosin has been researched along with Cardiac Failure in 6 studies
Terazosin: induces decreased blood pressure; used in the treatment of benign prostatic hyperplasia
| Excerpt | Relevance | Reference |
|---|---|---|
| "To determine the hemodynamic effects of a new alpha-1 blocker, terazosin, in congestive heart failure, 10 patients with this condition underwent hemodynamic testing at rest." | 7.68 | Hemodynamic effects of terazosin in congestive heart failure. ( Liu, Z; Lu, Z; Wang, D; Yang, D; Zhu, J, 1993) |
| "To determine the hemodynamic effects of a new alpha 1 blocker, terazosin, in congestive heart failure, six patients with this condition underwent hemodynamic testing (at rest and during exercise) before and after dosing." | 7.67 | The hemodynamic and clinical responses to terazosin, a new alpha blocking agent, in congestive heart failure. ( Huss, P; Leier, CV; Parrish, D; Patterson, SE; Unverferth, DV, 1986) |
| "Terazosin is a new long-acting, selective alpha 1-adrenergic antagonist." | 6.37 | Terazosin: a new long-acting alpha 1-adrenergic antagonist for hypertension. ( Eisen, G; Frishman, WH; Lapsker, J, 1988) |
| "Ten patients with congestive heart failure (class III and IV) underwent hemodynamic evaluation before and after a 5-mg oral dose of terazosin." | 5.28 | Rest and exercise cardiovascular effects of terazosin in congestive heart failure. ( Boudoulas, H; Leier, CV; Magorien, RD; Sinnathamby, S; Unverferth, DV, 1990) |
| "To determine the hemodynamic effects of a new alpha-1 blocker, terazosin, in congestive heart failure, 10 patients with this condition underwent hemodynamic testing at rest." | 3.68 | Hemodynamic effects of terazosin in congestive heart failure. ( Liu, Z; Lu, Z; Wang, D; Yang, D; Zhu, J, 1993) |
| "To investigate intrarenal hemodynamics and effects of alpha 1-adrenergic blockade on glomerular functions in congestive heart failure (CHF), micropuncture studies were performed before and after intravenous injection of terazosin (1 microgram/100 g body wt iv) in eight myocardial infarction (MI) and in nine sham-operated rats after intraperitoneal injection of Inactin (70 mg/kg)." | 3.68 | Effects of alpha 1-adrenergic blockade on intrarenal hemodynamics in heart failure rats. ( Frohlich, ED; Nishikimi, T; Uchino, K, 1992) |
| "The pharmacokinetics of terazosin have been assessed in human volunteers, hypertensive patients, a limited number of elderly volunteers, and a small number of patients with congestive heart failure." | 3.67 | Pharmacokinetics of terazosin. ( Sonders, RC, 1986) |
| "To determine the hemodynamic effects of a new alpha 1 blocker, terazosin, in congestive heart failure, six patients with this condition underwent hemodynamic testing (at rest and during exercise) before and after dosing." | 3.67 | The hemodynamic and clinical responses to terazosin, a new alpha blocking agent, in congestive heart failure. ( Huss, P; Leier, CV; Parrish, D; Patterson, SE; Unverferth, DV, 1986) |
| "Terazosin is a new long-acting, selective alpha 1-adrenergic antagonist." | 2.37 | Terazosin: a new long-acting alpha 1-adrenergic antagonist for hypertension. ( Eisen, G; Frishman, WH; Lapsker, J, 1988) |
| "Ten patients with congestive heart failure (class III and IV) underwent hemodynamic evaluation before and after a 5-mg oral dose of terazosin." | 1.28 | Rest and exercise cardiovascular effects of terazosin in congestive heart failure. ( Boudoulas, H; Leier, CV; Magorien, RD; Sinnathamby, S; Unverferth, DV, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (50.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhu, J | 1 |
| Wang, D | 1 |
| Lu, Z | 1 |
| Liu, Z | 1 |
| Yang, D | 1 |
| Nishikimi, T | 1 |
| Uchino, K | 1 |
| Frohlich, ED | 1 |
| Magorien, RD | 1 |
| Sinnathamby, S | 1 |
| Leier, CV | 2 |
| Boudoulas, H | 1 |
| Unverferth, DV | 2 |
| Sonders, RC | 1 |
| Patterson, SE | 1 |
| Huss, P | 1 |
| Parrish, D | 1 |
| Frishman, WH | 1 |
| Eisen, G | 1 |
| Lapsker, J | 1 |
1 review available for terazosin and Cardiac Failure
| Article | Year |
|---|---|
Terazosin: a new long-acting alpha 1-adrenergic antagonist for hypertension.
Topics: Adrenergic alpha-Antagonists; Animals; Heart Failure; Humans; Hypertension; Prazosin | 1988 |
5 other studies available for terazosin and Cardiac Failure
| Article | Year |
|---|---|
Hemodynamic effects of terazosin in congestive heart failure.
Topics: Adolescent; Adrenergic alpha-Antagonists; Adult; Aged; Female; Heart Failure; Hemodynamics; Humans; | 1993 |
Effects of alpha 1-adrenergic blockade on intrarenal hemodynamics in heart failure rats.
Topics: Adrenergic alpha-Antagonists; Animals; Glomerular Filtration Rate; Heart Failure; Hemodynamics; Kidn | 1992 |
Rest and exercise cardiovascular effects of terazosin in congestive heart failure.
Topics: Adrenergic alpha-Antagonists; Coronary Circulation; Exercise; Female; Heart Failure; Hemodynamics; H | 1990 |
Pharmacokinetics of terazosin.
Topics: Administration, Oral; Adrenergic alpha-Antagonists; Aged; Animals; Blood Proteins; Chemical Phenomen | 1986 |
The hemodynamic and clinical responses to terazosin, a new alpha blocking agent, in congestive heart failure.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Dose-Response Relationship, Drug; Exercise Test; Female; | 1986 |